By Matthew Herper The U.S. government is pledging $215 million — and as much as $375 million — to two biotechnology companies working to pioneer faster, more efficient ways to make vaccines for influenza. As was evident when the outbreak of the H1N1 swine flu swept across the country in 2009, our system for making […]